Accéder au contenu
Merck

Serum amyloid A induces NLRP-3-mediated IL-1β secretion in neutrophils.

PloS one (2014-05-23)
Kiyoshi Migita, Yasumori Izumi, Yuka Jiuchi, Hideko Kozuru, Chieko Kawahara, Minoru Nakamura, Tadashi Nakamura, Kazunaga Agematsu, Junya Masumoto, Michio Yasunami, Atsushi Kawakami, Katsumi Eguchi
RÉSUMÉ

Serum amyloid A (SAA) is an acute phase reactant with significant immunological activities, including effects on cytokine synthesis and neutrophil chemotaxis. Neutrophils can also release cytokines with proinflammatory properties. IL-1β is a key proinflammatory cytokine, the secretion of which is controlled by inflammasome. We investigated the proinflammatory effects of SAA in vitro in relation to the NLRP3 inflammasome in neutrophils. Human neutrophils isolated form healthy subjects were stimulated with serum amyloid A (SAA). The cellular supernatants were analyzed by western blot using anti-IL-1β or anti-caspase-1 antibodies. IL-1β or Nod-like receptor family, pyrin domain containing 3 (NLRP3) mRNA expressions were analyzed by real-time PCR or reverse transcription-PCR (RT-PCR) method. SAA stimulation induced pro-IL-1β mRNA expression in neutrophils. Furthermore, SAA engaged the caspase-1-activating inflammasome, resulting in the production of active IL-1β. SAA-induced pro-IL-1β expression was marginally suppressed by the Syk specific inhibitor, R406, and SAA-induced pro-IL-1β processing in neutrophils was prevented by R406. Furthermore, SAA-induced NLRP3 mRNA expression was completely blocked by R406. Analysis of intracellular signaling revealed that SAA stimulation activated the tyrosine kinase Syk and mitogen-activated protein kinase (MAPK). These results demonstrate that the innate neutrophil immune response against SAA involves a two-step activation process: an initial signal promoting expression of pro-IL-1β and a second signal involving Syk-dependent activation of the NLRP3 inflammasome and caspase-1, allowing processing of pro-IL-1β and secretion of mature IL-1β.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Apo-SAA human, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)